Is aspirin safe for patients with heart failure?
作者信息
Cleland J G, Bulpitt C J, Falk R H, Findlay I N, Oakley C M, Murray G, Poole-Wilson P A, Prentice C R, Sutton G C
机构信息
Western Infirmary, Glasgow.
出版信息
Br Heart J. 1995 Sep;74(3):215-9. doi: 10.1136/hrt.74.3.215.
Abstract
摘要
相似文献
1
Is aspirin safe for patients with heart failure?
Br Heart J. 1995 Sep;74(3):215-9. doi: 10.1136/hrt.74.3.215.
2
Antithrombotic therapy in heart failure.
Expert Rev Cardiovasc Ther. 2006 May;4(3):277-8. doi: 10.1586/14779072.4.3.277.
3
Is the lower mortality in patients treated with aspirin and angiotensin-converting enzyme inhibitors due to decreased norepinephrine release?
J Am Coll Cardiol. 2000 Mar 1;35(3):817-9. doi: 10.1016/s0735-1097(99)00618-x.
4
5
Use of aspirin in conjunction with angiotensin-converting enzyme inhibitors does not worsen long-term survival in heart failure.
Int J Cardiol. 2003 Apr;88(2-3):207-14. doi: 10.1016/s0167-5273(02)00401-1.
6
Heart failure: a diagnostic and therapeutic dilemma in elderly patients.
Age Ageing. 1999 May;28(3):328-9. doi: 10.1093/ageing/28.3.328.
7
Aspirin and heart failure: square evidence meets a round patient.
Congest Heart Fail. 2003 Jul-Aug;9(4):203-5. doi: 10.1111/j.1527-5299.2003.01716.x.
8
Aspirin and mortality in patients treated with angiotensin-converting enzyme inhibitors: a cohort study of 11,575 patients with coronary artery disease.
J Am Coll Cardiol. 1999 Jun;33(7):1920-5. doi: 10.1016/s0735-1097(99)00129-1.
9
[Which interactions are there for equal doses of acetylsalicylic acid and ACE inhibitors?].
Dtsch Med Wochenschr. 2003 Feb 21;128(8):398. doi: 10.1055/s-2003-37373.
10
Controversies in heart failure. Are beneficial effects of angiotensin-converting enzyme inhibitors attenuated by aspirin in patients with heart failure?
Cardiol Clin. 2001 Nov;19(4):597-603. doi: 10.1016/s0733-8651(05)70246-0.
引用本文的文献
1
Korean Society of Heart Failure Guidelines for the Management of Heart Failure: Management of the Underlying Etiologies and Comorbidities of Heart Failure.
Int J Heart Fail. 2023 Jul 13;5(3):127-145. doi: 10.36628/ijhf.2023.0016. eCollection 2023 Jul.
2
Korean Society of Heart Failure Guidelines for the Management of Heart Failure: Management of the Underlying Etiologies and Comorbidities of Heart Failure.
Korean Circ J. 2023 Jul;53(7):425-451. doi: 10.4070/kcj.2023.0114.
3
Fighting against sudden death: a single or multidisciplinary approach.
J Interv Card Electrophysiol. 2006 Dec;17(3):205-10. doi: 10.1007/s10840-006-9077-6. Epub 2007 Apr 6.
4
Does aspirin attenuate the beneficial effect of ACE inhibitors in elderly people with heart failure?
Drugs Aging. 2005;22(7):605-14. doi: 10.2165/00002512-200522070-00006.
5
Blood coagulation in patients with chronic heart failure: evidence for hypercoagulable state and potential for pharmacological intervention.
Drugs. 2003;63(6):565-76. doi: 10.2165/00003495-200363060-00004.
6
Effect of aspirin on vasodilation to bradykinin and substance P in patients with heart failure treated with ACE inhibitor.
Br J Clin Pharmacol. 2002 Jan;53(1):37-42. doi: 10.1046/j.0306-5251.2001.01524.x.
7
Chronic aspirin is effective--if data are massaged sufficiently.
BMJ. 2002 Feb 2;324(7332):295.
8
Preventing atherosclerotic events with aspirin.
BMJ. 2002 Jan 12;324(7329):103-5. doi: 10.1136/bmj.324.7329.103.
9
Aspirin and ACE-inhibitors: for wedding or funeral?
J Thromb Thrombolysis. 2001 Apr;11(2):163-9. doi: 10.1023/a:1011232918173.
10
Interaction between aspirin and ACE inhibitors in patients with heart failure.
Drug Saf. 2001;24(3):167-82. doi: 10.2165/00002018-200124030-00002.
本文引用的文献
1
Platelet function, thrombin and fibrinolytic activity in patients with heart failure.
Eur Heart J. 1993 Feb;14(2):205-12. doi: 10.1093/eurheartj/14.2.205.
2
Fat-suppressed breath-hold magnetic resonance coronary angiography.
Circulation. 1993 Jan;87(1):94-104. doi: 10.1161/01.cir.87.1.94.
3
Low incidence of stroke in ambulatory patients with heart failure: a prospective study.
Am Heart J. 1993 Jul;126(1):141-6. doi: 10.1016/s0002-8703(07)80021-4.
4
The clinical course of heart failure and its modification by ACE inhibitors: insights from recent clinical trials.
Eur Heart J. 1994 Jan;15(1):125-30. doi: 10.1093/oxfordjournals.eurheartj.a060364.
5
Relationship between hemostatic abnormalities and neuroendocrine activity in heart failure.
Am Heart J. 1994 Mar;127(3):607-12. doi: 10.1016/0002-8703(94)90670-x.
6
Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials.
Arch Intern Med. 1994 Jul 11;154(13):1449-57.
7
Management of heart failure. IV. Anticoagulation for patients with heart failure due to left ventricular systolic dysfunction.
JAMA. 1994;272(20):1614-8. doi: 10.1001/jama.272.20.1614.
8
ACE inhibitors for heart failure: a question of dose.
Br Heart J. 1994 Sep;72(3 Suppl):S106-10. doi: 10.1136/hrt.72.3_suppl.s106.
9
Enhanced basal nitric oxide production in heart failure: another failed counter-regulatory vasodilator mechanism?
Lancet. 1994 Aug 6;344(8919):371-3. doi: 10.1016/s0140-6736(94)91402-8.
10
Peripheral haemodynamic effects of inhibition of prostaglandin synthesis in congestive heart failure and interactions with captopril.
Br Heart J. 1995 May;73(5):434-41. doi: 10.1136/hrt.73.5.434.
Zotero 插件